James B. Weissman
2013
In 2013, James B. Weissman earned a total compensation of $724.6K as Chief Business Officer at Dicerna Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $110,625 |
|---|---|
| Option Awards | $307,249 |
| Salary | $295,000 |
| Other | $11,698 |
| Total | $724,572 |
Weissman received $307.2K in option awards, accounting for 42% of the total pay in 2013.
Weissman also received $110.6K in non-equity incentive plan, $295K in salary and $11.7K in other compensation.
Rankings
In 2013, James B. Weissman's compensation ranked 7,975th out of 12,286 executives tracked by ExecPay. In other words, Weissman earned more than 35.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,975 out of 12,286 | 35th |
Division Manufacturing | 2,888 out of 4,612 | 37th |
Major group Chemicals And Allied Products | 901 out of 1,462 | 38th |
Industry group Drugs | 684 out of 1,156 | 41st |
Industry Pharmaceutical Preparations | 543 out of 890 | 39th |
Source: SEC filing on April 30, 2014.
Weissman's colleagues
We found three more compensation records of executives who worked with James B. Weissman at Dicerna Pharmaceuticals in 2013.